Thiazolidinediones and Glucagon‐Like Peptide‐1 Receptor Agonists and the Risk of Nonalcoholic Fatty Liver Disease: A Cohort Study

por van Dalem, Judith, Driessen, Johanna H. M., Burden, Andrea M., Stehouwer, Coen D. A., Klungel, Olaf H., de Vries, Frank, Brouwers, Martijn C. G. J.
Publicado 2021

Risk of a first‐ever acute myocardial infarction and all‐cause mortality with sulphonylurea treatment: A population‐based cohort study

por van Dalem, Judith, Brouwers, Martijn C. G. J., Stehouwer, Coen D. A., Krings, André, Klungel, Olaf H., Driessen, Johanna H. M., de Vries, Frank, Burden, Andrea M.
Publicado 2017

Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort study

por van Dalem, Judith, Brouwers, Martijn C G J, Stehouwer, Coen D A, Krings, André, Leufkens, Hubert G M, Driessen, Johanna H M, de Vries, Frank, Burden, Andrea M
Publicado 2016